EXICURE, INC. Gain (Loss) on Termination of Lease
EXICURE, INC. (XCUR) reported Gain (Loss) on Termination of Lease of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-14
- EXICURE, INC. gain (loss) on termination of lease for the quarter ending 2026-06-30 was $0.00.
- EXICURE, INC. gain (loss) on termination of lease for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. gain (loss) on termination of lease for the quarter ending 2025-09-30 was $0.00.
- EXICURE, INC. gain (loss) on termination of lease for the quarter ending 2025-06-30 was $0.00.
- EXICURE, INC. gain (loss) on termination of lease for fiscal 2025 was $5.97M.
- EXICURE, INC. gain (loss) on termination of lease for fiscal 2024 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-29 | |||
| 2025-12-31 | $5.97M 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | $5.97M 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $5.97M 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $5.97M 10-Q · filed 2026-05-29 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |